Publication | Open Access

Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504

Nivolumab AddedChemoradiation Therapy PlatformsRadiation TherapyMedicineRtog Foundation 3504Head And Neck CancerHead And Neck SurgeryCancer TreatmentNeck OncologyOncologyRadiation OncologyRadiologyHealth Sciences